UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 861177
NEW YORK, NY
Position in ARCT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,008
-$1,787 QoQ
Shares Held
1,787
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 133 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ARCT ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ARCT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,008 | 1,787 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $13,795 | 1,787 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,743 | 1,100 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $502,515 | 47,452 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $885,643 | 52,189 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,775,593 | 205,756 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,005,187 | 205,552 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,092,038 | 180,398 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $818,326 | 25,954 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $593,958 | 23,247 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $484,546 | 16,895 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $404,970 | 16,895 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $476,975 | 17,692 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $654,779 | 17,692 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $905,191 | 18,945 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $631,995 | 18,676 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $670,092 | 16,225 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $633,348 | 14,600 | Shares | Sole | 2021-03-01 | |
| 2020-09-30 | $613,470 | 14,300 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $518,814 | 11,100 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||